Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) Cyclically Adjusted FCF per Share: NT$-0.29 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:1762 Chunghwa Chemical Synthesis & Biotech Co Ltd TPE:1762
59 GF Score
Price NT$34.75
GF Value NT$38.77
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Chunghwa Chemical Synthesis & Biotech Co Cyclically Adjusted FCF per Share?

Chunghwa Chemical Synthesis & Biotech Co TPE:1762 +0.72% 59 Cyclically Adjusted FCF per Share is NT$-0.29 as of Dec. 2025. GuruFocus rates TPE:1762 with a GF Score™ of 59/100 and a GF Value™ of NT$38.77 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Chunghwa Chemical Synthesis & Biotech Co's adjusted free cash flow per share for the three months ended in Dec. 2025 was NT$-0.667. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is NT$-0.29 for the trailing ten years ended in Dec. 2025.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 11.60% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 24.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Chunghwa Chemical Synthesis & Biotech Co was 32.30% per year. The lowest was 1.10% per year. And the median was 14.75% per year.

As of today (2026-07-27), Chunghwa Chemical Synthesis & Biotech Co's current stock price is NT$34.75. Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2025 was NT$-0.29. Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted Price-to-FCF of today is .


Chunghwa Chemical Synthesis & Biotech Co  (TPE:1762) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Chunghwa Chemical Synthesis & Biotech Co Cyclically Adjusted FCF per Share Related Terms


Chunghwa Chemical Synthesis & Biotech Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chunghwa Chemical Synthesis & Biotech Co Cyclically Adjusted FCF per Share Chart

Chunghwa Chemical Synthesis & Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.64 -0.42 -1.16 -0.51 -0.29

Chunghwa Chemical Synthesis & Biotech Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.51 -0.22 -0.38 -0.22 -0.29

TPE:1762 vs VRTX, REGN, RVMD: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chunghwa Chemical Synthesis & Biotech Co Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted Price-to-FCF falls into.


TPE:1762
59GF Score
Chunghwa Chemical Synthesis & Biotech Co Ltd TPE:1762
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chunghwa Chemical Synthesis & Biotech Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Chunghwa Chemical Synthesis & Biotech Co's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=-0.667/324.0540*324.0540
=-0.667

Current CPI (Dec. 2025) = 324.0540.

Chunghwa Chemical Synthesis & Biotech Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201603 0.621 238.132 0.845
201606 0.117 241.018 0.157
201609 0.151 241.428 0.203
201612 0.989 241.432 1.327
201703 0.354 243.801 0.471
201706 -1.072 244.955 -1.418
201709 -2.278 246.819 -2.991
201712 -5.276 246.524 -6.935
201803 1.663 249.554 2.159
201806 0.276 251.989 0.355
201809 -0.044 252.439 -0.056
201812 -0.089 251.233 -0.115
201903 0.209 254.202 0.266
201906 1.029 256.143 1.302
201909 0.218 256.759 0.275
201912 0.492 256.974 0.620
202003 0.167 258.115 0.210
202006 0.632 257.797 0.794
202009 -0.927 260.280 -1.154
202012 -0.557 260.474 -0.693
202103 1.254 264.877 1.534
202106 -2.293 271.696 -2.735
202109 -1.247 274.310 -1.473
202112 -0.106 278.802 -0.123
202203 0.801 287.504 0.903
202206 2.302 296.311 2.518
202209 0.958 296.808 1.046
202212 0.516 296.797 0.563
202303 -3.974 301.836 -4.267
202306 1.275 305.109 1.354
202309 -3.772 307.789 -3.971
202312 -0.113 306.746 -0.119
202403 -3.401 312.332 -3.529
202406 5.254 314.175 5.419
202409 0.573 315.301 0.589
202412 2.258 315.605 2.318
202503 0.957 319.799 0.970
202506 -0.717 322.561 -0.720
202509 1.870 324.800 1.866
202512 -0.667 324.054 -0.667

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of NT$-0.29 mean?
Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) has a Cyclically Adjusted FCF per Share of NT$-0.29 as of Dec. 2025. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Chunghwa Chemical Synthesis & Biotech Co and its competitors.
Is Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted FCF per Share too high?
Chunghwa Chemical Synthesis & Biotech Co's current Cyclically Adjusted FCF per Share is NT$-0.29. Overall, Chunghwa Chemical Synthesis & Biotech Co has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted FCF per Share compare to VRTX and REGN?
Chunghwa Chemical Synthesis & Biotech Co's Cyclically Adjusted FCF per Share of NT$-0.29 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Chunghwa Chemical Synthesis & Biotech Co and its competitors. Chunghwa Chemical Synthesis & Biotech Co's current Cyclically Adjusted FCF per Share is NT$-0.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chunghwa Chemical Synthesis & Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$38.77, compared to a current price of NT$34.75 — trading 10.4% below its estimated fair value. The current Cyclically Adjusted FCF per Share is NT$-0.29. Chunghwa Chemical Synthesis & Biotech Co's overall GF Score™ is 59/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Chunghwa Chemical Synthesis & Biotech Co (TPE:1762), the current Cyclically Adjusted FCF per Share is NT$-0.29 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) Overvalued in 2026?

Based on GuruFocus' analysis, Chunghwa Chemical Synthesis & Biotech Co stock appears to be undervalued. The current stock price of NT$34.75 is trading 10.4% below its estimated GF Value™ of NT$38.77. GuruFocus considers Chunghwa Chemical Synthesis & Biotech Co to be Modestly Undervalued.

Key valuation signals for TPE:1762:

  • Cyclically Adjusted FCF per Share: NT$-0.29
  • GF Value™: NT$38.77 vs. price of NT$34.75 (10.4% below fair value)
  • GF Score™: 59/100 with 5 warning signs

No single metric tells the full story. See the TPE:1762 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Chunghwa Chemical Synthesis & Biotech Co Business Description

Address No. 1, Dongxing Street, Shulin District, Taipei, TWN
Chunghwa Chemical Synthesis & Biotech Co Ltd is engaged in the research, development, manufacturing, and sales of pharmaceutical products. Geographically, it derives a majority of its revenue from the United States and also has a presence in Taiwan. Its product portfolio comprises pain management, antifungal, immunosuppressant, oncology, Cardiovascular, Peptide Drugs, and Others.
59GF Score

Get the complete analysis for TPE:1762

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$34.75
Price
NT$38.77
GF Value